Number of the records: 1

omalizumab

SYS		d000069444
LBL		00000nx^^^2200181-^^45^^
005		20240119195246.6
100		$a 20160101asloy0103 ba0
152		$b mesh
250		$a omalizumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo
300	1-	$a 2016 (2001) $8 eng
330	1-	$a An anti-IgE, recombinant, humanized monoclonal antibody which specifically binds to the C epsilon3 domain of IMMUNOGLOBULIN E, the site of high-affinity IgE receptor binding. It inhibits the binding of IgE to MAST CELLS and BASOPHILS to reduce the severity of the allergic response and is used in the management of persistent allergic ASTHMA. $8 eng
686		$a D12.776.124.486.485.114.071.500
686		$a D12.776.124.486.485.114.224.060.844
686		$a D12.776.124.790.651.114.071.500
686		$a D12.776.124.790.651.114.224.060.844
686		$a D12.776.377.715.548.114.071.500
686		$a D12.776.377.715.548.114.224.200.844
750		$a Omalizumab $8 eng
801	-0	$a SK $b BA006 $c 20160207
801	-2	$a SK $b BA006 $c 20160209
980		$x M

Number of the records: 1